Related Experiment Video
Updated: Jan 17, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Periconceptual Caffeine Intake and Adverse Pregnancy Outcomes: Results From the nuMoM2b Cohort
Rachel S Ruderman1, Alexa A Freedman2, Sunitha C Suresh3
1University of Chicago/Endeavor Health, Chicago, Illinois, USA.
Objective:
To determine the association of self-assessed caffeine consumption with adverse pregnancy outcomes (APO).
Design:
Secondary analysis of births in the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be (nuMoM2b). Caffeine intake was assessed by the self-reported Food Frequency Questionnaire reflecting consumption in the three months prior to the first trimester visit.
Setting:
nuMoM2b was a prospectively collected cohort.
Population:
This is a large US-based cohort of pregnant patients.
Methods:
High caffeine intake was defined as ≥ 200 mg/day. Logistic models assessed associations between high intake and APO, adjusted for confounders. We also grouped caffeine intake in 50 mg increments and tested whether increased consumption was associated with increased odds of APO.
Main Outcome Measures:
APO were defined as a composite of intrauterine foetal demise > 20 weeks' gestation, hypertensive disorders of pregnancy, preterm birth and small for gestational age infant.
Results:
The primary analysis included 7345 participants with live births or pregnancy loss > 20 weeks' gestation, for whom the median daily caffeine intake was 63.28 mg/day. 841 (11.4%) of patients had high intake and 2168 (29.5%) had an APO. When adjusted for confounders, high intake was not associated with increased odds of APO (aOR 0.99, 95% CI 0.84-1.16), nor was it associated with any individual APO. We found no significant increased odds of APO per 50 mg increase in caffeine intake.
Conclusions:
High caffeine intake assessed in the periconceptual period was not associated with the risk of APO. Further research exploring biomarkers and longitudinal childhood outcomes is needed to clarify limitations with regard to intake.
More Related Videos
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
Teratogenicity
Experimental Designs
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Diabetes Mellitus: Type 2 and Gestational
Confounding in Epidemiological Studies
Bioavailability Study Design: Healthy Subjects Versus Patients